FR2684554B1 - Medicaments pour le traitement d'etats inflammatoires ou pour l'analgesie. - Google Patents

Medicaments pour le traitement d'etats inflammatoires ou pour l'analgesie.

Info

Publication number: FR2684554B1
Authority: FR; France
Prior art keywords: analgesia; medicines; treatment; inflammatory conditions; inflammatory
Prior art date: 1991-12-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR9214642A

Other languages

English (en)

Other versions

FR2684554A1 (fr

Inventor

Roger Stables

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Glaxo Group Ltd

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-12-06

Filing date

1992-12-04

Publication date

1995-09-08

1991-12-06 Priority claimed from GB919126027A external-priority patent/GB9126027D0/en

1992-03-20 Priority claimed from GB929206083A external-priority patent/GB9206083D0/en

1992-12-04 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1993-06-11 Publication of FR2684554A1 publication Critical patent/FR2684554A1/fr

1995-09-08 Application granted granted Critical

1995-09-08 Publication of FR2684554B1 publication Critical patent/FR2684554B1/fr

2012-12-04 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

FR9214642A 1991-12-06 1992-12-04 Medicaments pour le traitement d'etats inflammatoires ou pour l'analgesie. Expired - Fee Related FR2684554B1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB919126027A GB9126027D0 (en)	1991-12-06	1991-12-06	Medicaments
GB929206083A GB9206083D0 (en)	1992-03-20	1992-03-20	Medicaments

Publications (2)

Publication Number	Publication Date
FR2684554A1 FR2684554A1 (fr)	1993-06-11
FR2684554B1 true FR2684554B1 (fr)	1995-09-08

Family

ID=26299971

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR9214642A Expired - Fee Related FR2684554B1 (fr)	1991-12-06	1992-12-04	Medicaments pour le traitement d'etats inflammatoires ou pour l'analgesie.

Country Status (26)

Country	Link
US (1)	US5466436A (fr)
EP (1)	EP0550083B1 (fr)
JP (1)	JPH05246853A (fr)
KR (1)	KR930009605A (fr)
AP (1)	AP324A (fr)
AT (1)	AT401468B (fr)
AU (1)	AU664574B2 (fr)
BE (1)	BE1007268A3 (fr)
CA (1)	CA2084568A1 (fr)
CH (1)	CH685537A5 (fr)
CZ (1)	CZ358092A3 (fr)
DE (1)	DE69228738D1 (fr)
DK (1)	DK0550083T3 (fr)
ES (1)	ES2130152T3 (fr)
FR (1)	FR2684554B1 (fr)
GB (1)	GB2262036B (fr)
GR (1)	GR3030426T3 (fr)
IE (1)	IE922866A1 (fr)
IL (1)	IL103978A (fr)
IT (1)	IT1256697B (fr)
LU (1)	LU88196A1 (fr)
MX (1)	MX9207008A (fr)
MY (1)	MY108146A (fr)
NO (1)	NO303670B1 (fr)
NZ (1)	NZ245365A (fr)
PH (1)	PH31380A (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69620582T2 (de) *	1995-01-26	2002-11-07	Nycomed Imaging As, Oslo	Verwendung von WISMUTVERBINDUNGEN zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden
GB9501560D0 (en) *	1995-01-26	1995-03-15	Nycomed Imaging As	Contrast agents
WO1998022117A1 (fr) *	1996-11-22	1998-05-28	The Procter & Gamble Company	Compositions de traitement de troubles gastro-intestinaux contenant du bismuth, des anti-inflammatoires non steroidiens ainsi qu'un ou plusieurs agents anti-microbiens et methodes correspondantes
TR199901101T2 (xx) *	1996-11-22	1999-07-21	The Procter & Gamble Company	Gastroenstentinal hastal�klar�n tedavisine y�nelik bizmut ve nsaid i�eren bile�imler.
SE0000773D0 (sv) *	2000-03-08	2000-03-08	Astrazeneca Ab	New formulation
SE0000774D0 (sv) *	2000-03-08	2000-03-08	Astrazeneca Ab	New formulation
KR100904599B1 (ko) *	2001-03-08	2009-06-25	아스트라제네카 아베	신규 용도
US8206741B2 (en)	2001-06-01	2012-06-26	Pozen Inc.	Pharmaceutical compositions for the coordinated delivery of NSAIDs
MXPA03011017A (es) *	2001-06-01	2005-04-29	Pozen Inc	Composiciones farmaceuticas para la entrega coordinada de nsaids.
SE0102993D0 (sv)	2001-09-07	2001-09-07	Astrazeneca Ab	New self emulsifying drug delivery system
US20080021078A1 (en) *	2006-07-18	2008-01-24	Horizon Therapeutics, Inc.	Methods and medicaments for administration of ibuprofen
US20080020040A1 (en) *	2006-07-18	2008-01-24	Horizon Therapeutics, Inc.	Unit dose form for administration of ibuprofen
CN101257800B (zh) *	2005-07-18	2012-07-18	好利用医疗公司	包含法莫替丁和布洛芬的药物
US8067451B2 (en) *	2006-07-18	2011-11-29	Horizon Pharma Usa, Inc.	Methods and medicaments for administration of ibuprofen
US8067033B2 (en)	2007-11-30	2011-11-29	Horizon Pharma Usa, Inc.	Stable compositions of famotidine and ibuprofen
WO2008027963A2 (fr) *	2006-08-31	2008-03-06	Horizon Therapeutics, Inc.	Formulations à dose unique d'ains avec antagonistes du récepteur de h2, et procédés d'utilisation
CA2736547C (fr)	2008-09-09	2016-11-01	Pozen Inc.	Procede d'administration d'une composition pharmaceutique a un patient en ayant besoin
JP2012531409A (ja)	2009-06-25	2012-12-10	アストラゼネカ・アクチエボラーグ	Ｎｓａｉｄ関連潰瘍を発症するリスクがある患者の処置方法
EP2797600A4 (fr)	2011-12-28	2015-09-16	Pozen Inc	Compositions et procédés d'administration d'oméprazole plus acide acétylsalicylique améliorés
CN110893233A (zh) *	2019-12-19	2020-03-20	川北医学院附属医院	一种鸢尾素在制备抗炎药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4464679A (en) *	1981-07-06	1984-08-07	Rca Corporation	Method and apparatus for operating a microprocessor in synchronism with a video signal
GB2105193B (en) *	1981-09-04	1984-09-12	Glaxo Group Ltd	Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
CA1211374A (fr) *	1982-05-14	1986-09-16	Eszter Cholnoky	Compose pharmaceutique contenant plus d'ingredients actifs
US4757060A (en) *	1986-03-04	1988-07-12	Bristol-Myers Company	Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
GB8625325D0 (en) *	1986-10-22	1986-11-26	Glaxo Group Ltd	Chemical compounds
IL85472A (en) *	1987-03-09	1991-06-30	Procter & Gamble	Pharmaceutical compositions for treating gastrointestinal disorders
DE3874917T2 (de) *	1987-03-09	1993-03-04	Procter & Gamble	Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
CH679582A5 (fr) *	1988-07-18	1992-03-13	Glaxo Group Ltd
NZ235877A (en) *	1989-11-02	1992-09-25	Mcneil Ppc Inc	Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
GB9019875D0 (en) *	1990-09-11	1990-10-24	Glaxo Group Ltd	Pharmaceutical compositions
US5128140A (en) *	1991-01-14	1992-07-07	The Procter & Gamble Company	Swallowable pharmaceutical compositions

1992
- 1992-11-27 EP EP92203674A patent/EP0550083B1/fr not_active Expired - Lifetime
- 1992-11-27 ES ES92203674T patent/ES2130152T3/es not_active Expired - Lifetime
- 1992-11-27 DK DK92203674T patent/DK0550083T3/da active
- 1992-11-27 DE DE69228738T patent/DE69228738D1/de not_active Expired - Lifetime
- 1992-12-02 GB GB9225174A patent/GB2262036B/en not_active Expired - Fee Related
- 1992-12-03 PH PH45371A patent/PH31380A/en unknown
- 1992-12-04 JP JP4325308A patent/JPH05246853A/ja active Pending
- 1992-12-04 CZ CS923580A patent/CZ358092A3/cs unknown
- 1992-12-04 LU LU88196A patent/LU88196A1/fr unknown
- 1992-12-04 NZ NZ245365A patent/NZ245365A/en unknown
- 1992-12-04 IT ITRM920869A patent/IT1256697B/it active IP Right Grant
- 1992-12-04 MY MYPI92002235A patent/MY108146A/en unknown
- 1992-12-04 AP APAP/P/1992/000453A patent/AP324A/en active
- 1992-12-04 BE BE9201070A patent/BE1007268A3/fr not_active IP Right Cessation
- 1992-12-04 IE IE286692A patent/IE922866A1/en not_active Application Discontinuation
- 1992-12-04 FR FR9214642A patent/FR2684554B1/fr not_active Expired - Fee Related
- 1992-12-04 CH CH3737/92A patent/CH685537A5/fr unknown
- 1992-12-04 KR KR1019920023309A patent/KR930009605A/ko not_active Ceased
- 1992-12-04 MX MX9207008A patent/MX9207008A/es not_active IP Right Cessation
- 1992-12-04 AU AU29863/92A patent/AU664574B2/en not_active Ceased
- 1992-12-04 IL IL103978A patent/IL103978A/en not_active IP Right Cessation
- 1992-12-04 NO NO924704A patent/NO303670B1/no unknown
- 1992-12-04 CA CA002084568A patent/CA2084568A1/fr not_active Abandoned
- 1992-12-04 AT AT0240692A patent/AT401468B/de not_active IP Right Cessation
1993
- 1993-12-17 US US08/168,231 patent/US5466436A/en not_active Expired - Fee Related
1999
- 1999-06-04 GR GR990401510T patent/GR3030426T3/el unknown

Also Published As

Publication number	Publication date
CZ358092A3 (en)	1993-10-13
DE69228738D1 (de)	1999-04-29
GB9225174D0 (en)	1993-01-20
AT401468B (de)	1996-09-25
BE1007268A3 (fr)	1995-05-09
LU88196A1 (fr)	1993-08-17
AP324A (en)	1994-03-07
AU2986392A (en)	1993-06-10
ITRM920869A0 (it)	1992-12-04
IL103978A0 (en)	1993-05-13
IL103978A (en)	1998-06-15
CH685537A5 (fr)	1995-08-15
NO303670B1 (no)	1998-08-17
CA2084568A1 (fr)	1993-06-07
NZ245365A (en)	1997-06-24
NO924704L (no)	1993-06-07
ES2130152T3 (es)	1999-07-01
IE922866A1 (en)	1993-06-16
ATA240692A (de)	1996-02-15
EP0550083B1 (fr)	1999-03-24
PH31380A (en)	1998-10-29
US5466436A (en)	1995-11-14
IT1256697B (it)	1995-12-12
DK0550083T3 (da)	1999-10-11
ITRM920869A1 (it)	1994-06-04
MY108146A (en)	1996-08-30
NO924704D0 (no)	1992-12-04
AU664574B2 (en)	1995-11-23
GB2262036A (en)	1993-06-09
GB2262036B (en)	1996-01-03
AP9200453A0 (en)	1993-01-31
GR3030426T3 (en)	1999-09-30
KR930009605A (ko)	1993-06-21
JPH05246853A (ja)	1993-09-24
MX9207008A (es)	1993-06-01
EP0550083A1 (fr)	1993-07-07
FR2684554A1 (fr)	1993-06-11

Publication	Publication Date	Title
FR2684554B1 (fr)	1995-09-08	Medicaments pour le traitement d'etats inflammatoires ou pour l'analgesie.
FR2685206B1 (fr)	1998-03-06	Dispositif de drainage implantable pour le traitement de l'hydrocephalie.
DZ1877A1 (fr)	2002-02-17	Forme posologiques d'azithromycine pour le traitement d'infection microbiennes.
FR2710541B1 (fr)	1998-12-04	Ensemble pour l'introduction d'un cathéter.
FR2710540B1 (fr)	1998-04-03	Ensemble pour l'introduction d'un cathéter.
FR2675597B1 (fr)	1995-03-17	Unite de traitement d'electrophotographie.
EP0601058A4 (fr)	1995-05-31	Formulations transdermiques pour l'administration de prazosine.
EP0673384A4 (fr)	1996-10-09	Polypeptides utiles pour traiter des troubles inflammatoires.
EP0563239A4 (fr)	1994-10-12	Gene recepteur tronque d'interleukine-1 utilise pour le traitement de l'arthrite.
FR2715060B1 (fr)	1999-04-23	Dispositif pour l'ozonisation de petites zones ou surfaces à des fins thérapeutiques.
FR2660301B1 (fr)	1992-07-10	Dispositif pour la production d'ozone.
FR2705966B1 (fr)	1995-08-25	Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
FR2660192B1 (fr)	1995-02-03	Formulation liposomiales pour l'administration topique ou vaginale de medicaments.
DZ1988A1 (fr)	2002-07-20	Thérapie de combinaison pour le traitement de l'hiv.
FR2558372B1 (fr)	1987-08-07	Composition medicamenteuse pour le traitement de l'acne
FR2658419B1 (fr)	1995-01-27	Medicament pour le traitement de la dermatite.
FR2718024B1 (fr)	1996-06-21	Médicament et composition pharmaceutique pour le traitement de l'inflammation.
FR2660300B1 (fr)	1992-07-10	Dispositif pour la production d'ozone.
FR2686251B1 (fr)	1994-04-29	Composition pour la cicatrisation d'une plaie.
FR2683722B1 (fr)	1995-05-24	Medicament pour le traitement de fond de l'asthme a base de beta-carotene.
BE894228A (fr)	1982-12-16	Composition pharmaceutique pour le traitement de l'atherosclerose
FR2544614B1 (fr)	1987-08-21	Nouvelle association medicamenteuse pour le traitement de l'hypertension
FR2670517B1 (fr)	1993-04-09	Element de franchissement pour le franchissement d'obstacles.
FR2691064B3 (fr)	1996-01-12	Nouveau medicament pour le traitement de l'arythmie.
OA08609A (fr)	1988-11-30	Composition pharmaceutique pour le traitement des infections bactériennes.

Legal Events

Date	Code	Title	Description
2000-10-13	ST	Notification of lapse